The Cohere story part two: the hard questions

The Cohere story part two: the hard questions

Up next

Relax, it’s probably not a cyber attack

Over the past week, a whole bunch of major tech outages have happened — affecting Microsoft, Apple, major banks, the U.S. National Security Administration, and temporarily grounding all flights across the United States.While officials and companies have repeatedly insisted that t ...  Show more

The priest with Carney’s ear on homelessness

Earlier this month, as part of the rollout of the federal budget, Prime Minister Mark Carney announced that with a near $30-billion investment, the federal government hopes to end homelessness in Canada in the next 10 years. While making that announcement in Winnipeg he quoted Re ...  Show more

Recommended Episodes

Halted: Johnson & Johnson & the Vaccination Timeline
Squawk Pod

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

Coronavirus: How Scary Are the Variants?
Science Vs

UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ...  Show more

Are all viral vector vaccines a problem?
What's That Rash?

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Show more